Gene · 1736
Papers2,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histone methyltransferase SETDB1 promotes osteogenic differentiation in osteoporosis by activating OTX2-mediated BMP-Smad and Wnt/β-catenin pathways. | Hum Cell | 2023 | 37074626 | PubTator, text mining | PubMed |
| Motif conservation, stability, and host gene expression are the main drivers of snoRNA expression across vertebrates. | Genome Res | 2023 | 37072185 | PubTator, text mining | PubMed |
| Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma. | Mol Cancer Ther | 2023 | 37070671 | PubTator, text mining | PubMed |
| A de novo TINF2, R282C Mutation in a Case of Dyskeratosis Congenital Founded by Next-Generation Sequencing. | Iran Biomed J | 2023 | 37070599 | PubTator, text mining | PubMed |
| The essential roles of small non-coding RNAs and RNA modifications in normal and malignant hematopoiesis. | Front Mol Biosci | 2023 | 37065445 | PubTator, text mining | PubMed |
| Progress in 7SK ribonucleoprotein structural biology. | Front Mol Biosci | 2023 | 37051324 | PubTator, text mining | PubMed |
| Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine. | Cells | 2023 | 37048073 | PubTator, text mining | PubMed |
| Specialized Ribosomes in Health and Disease. | Int J Mol Sci | 2023 | 37047306 | PubTator, text mining | PubMed |
| Nucleic Acids in Cancer Diagnosis and Therapy. | Cancers (Basel) | 2023 | 37046599 | PubTator, text mining | PubMed |
| T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers. | Cancer Cell | 2023 | 37037617 | PubTator, text mining | PubMed |
| Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights. | Front Cell Dev Biol | 2023 | 37035242 | PubTator, text mining | PubMed |
Predicting Mechanical Complications After Adult Spinal Deformity Operation Using a Machine Learning Based on Modified Global Alignment and Proportion Scoring With Body Mass Index and Bone Mineral Density. | Neurospine | 2023 | 37016873 | PubTator, text mining | PubMed |
| Unlocking the potential of induced pluripotent stem cells for neonatal disease modeling and drug development. | Semin Perinatol | 2023 | 37012138 | PubTator, text mining | PubMed |
| The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action. | Hemasphere | 2023 | 37008163 | PubTator, text mining | PubMed |
| Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia. | Commun Biol | 2023 | 37002311 | PubTator, text mining | PubMed |
| Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma. | Front Pharmacol | 2023 | 36998605 | PubTator, text mining | PubMed |
| Quantitative profiling of pseudouridylation landscape in the human transcriptome. | Nat Chem Biol | 2023 | 36997645 | PubTator, text mining | PubMed |
| Dendrimer-Mediated Delivery of Anticancer Drugs for Colon Cancer Treatment. | Pharmaceutics | 2023 | 36986662 | PubTator, text mining | PubMed |
| The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia. | Genes (Basel) | 2023 | 36980962 | PubTator, text mining | PubMed |
| A dual-purpose polymerase engineered for direct sequencing of pseudouridine and queuosine. | Nucleic Acids Res | 2023 | 36971106 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1736/papers?page=12